TrialJournal of thrombosis and thrombolysis2016

Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial.

Sebastian Werth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.